Film i Väst

Film i Väst is Scandinavia’s leading film fund and has co-produced more than 1 300 films and drama series since 1992. Thanks to great co-operation with Swedish and international producers over 100 films have been screened in Cannes, Berlin, Venice, Toronto. Our co-productions have received seventeen Oscar nominations since 2011 and twelve Palme d’Or nominations including Ruben Östlund’s winners The Square and Triangle of Sadness. Thomas Vinterberg won an Oscar in 2021 for Another Round, and Joachim Trier’s The Worst Person in the World was double nominated for Oscars in 2022. In 2023 Ruben Östlund’s Triangle of Sadness was triple nominated for an Oscar and Oliver Hermanus Living double nominated. Film i Väst is a part of Region Västra Götaland.

Trollhattan, Vastra Gotaland
Founded in 1992
11-50 employees

Film i Väst is Scandinavia’s leading film fund and has co-produced more than 1 300 films and drama series since 1992. Thanks to great co-operation with Swedish and international producers over 100 films have been screened in Cannes, Berlin, Venice, Toronto. Our co-productions have received seventeen Oscar nominations since 2011 and twelve Palme d’Or nominations including Ruben Östlund’s winners The Square and Triangle of Sadness. Thomas Vinterberg won an Oscar in 2021 for Another Round, and Joachim Trier’s The Worst Person in the World was double nominated for Oscars in 2022. In 2023 Ruben Östlund’s Triangle of Sadness was triple nominated for an Oscar and Oliver Hermanus Living double nominated. Film i Väst is a part of Region Västra Götaland.

Company Information

Industry
Company Type
Public Company
Founded
1992
Employee Range
11-50
Revenue Range
Not available

Location

Address
Box 134 Västra Götaland Trollhättan
City
Trollhattan
Region
Vastra Gotaland
Postal Code
461 23
Country
Sweden

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions